Clinical Trials for Metastatic Oropharyngeal Squamous Cell Carcinoma

Find clinical trials for metastatic oropharyngeal squamous cell carcinoma. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

NCT ID: NCT06589804

This clinical trial is studying whether adding a medication called cetuximab to the standard treatment pembrolizumab can better help patients with certain types of head and neck cancers that have r...

Recruiting

Phase: PHASE3 Type: interventional Locations: Saint Louis, Missouri, United States, Flint, Michigan, United States +98 more

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT ID: NCT05136196

The BiCaZO trial is studying the effects of a combination of two drugs, cabozantinib and nivolumab, on patients with advanced melanoma or squamous cell head and neck cancers. These cancers may have...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Milwaukee, Wisconsin, United States +228 more

TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer

NCT ID: NCT06868433

This clinical trial is testing a new treatment approach for patients with certain types of head and neck cancer that has either returned after treatment or spread to other parts of the body. The st...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Atlanta, Georgia, United States, Atlanta, Georgia, United States

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

NCT ID: NCT06662058

This clinical trial is looking at how offering hearing tests close to home or through remote options can help monitor hearing loss in patients with certain types of head and neck cancers who are re...

Recruiting

Phase: NA Type: interventional Locations: Atlanta, Georgia, United States

Lovastatin and Pembrolizumab for the Treatment of Patients with Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

NCT ID: NCT06636734

The LAPP Trial is a research study looking at how well two medications, lovastatin and pembrolizumab, work together to treat patients with certain types of head and neck cancer that have either ret...

Recruiting

Phase: PHASE2 Type: interventional Locations: Atlanta, Georgia, United States

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

NCT ID: NCT05721755

This clinical trial is studying a new treatment approach for patients with advanced squamous cell carcinoma of the head and neck, specifically looking at whether combining radiation therapy with pe...

Recruiting

Phase: PHASE3 Type: interventional Locations: Cleveland, Ohio, United States, Charleston, South Carolina, United States +50 more

Oropharynx (OPX) Biomarker Trial

NCT ID: NCT06356272

The Oropharynx Biomarker Trial is a research study focused on finding a specific biological marker linked to certain types of throat cancer caused by the human papillomavirus (HPV). The goal is to ...

Recruiting

Type: observational Locations: Rochester, Minnesota, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions